Cargando…
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study
BACKGROUND: The itAlian pRospective Study on CANGrELOr (ARCANGELO) was aimed to assess the safety of using cangrelor during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) in the daily practice. HYPOTHESIS: The safety of cangrelor after the transition to oral...
Autores principales: | De Luca, Leonardo, Calabrò, Paolo, Chirillo, Fabio, Rolfo, Cristina, Menozzi, Alberto, Capranzano, Piera, Menichelli, Maurizio, Nicolini, Elisa, Mauro, Ciro, Trani, Carlo, Versaci, Francesco, Tomai, Fabrizio, Musumeci, Giuseppe, Di Mario, Carlo, Pepe, Martino, Berti, Sergio, Cernetti, Carlo, Cirillo, Plinio, Maffeo, Diego, Talanas, Giuseppe, Ferlini, Marco, Contarini, Marco, Lanzilotti, Valerio, Scherillo, Marino, Tarantini, Giuseppe, Muraglia, Simone, Rossini, Roberta, Bolognese, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451664/ https://www.ncbi.nlm.nih.gov/pubmed/35733352 http://dx.doi.org/10.1002/clc.23878 |
Ejemplares similares
-
Safety of cangrelor and transition to oral P2Y(12) inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study
por: De Luca, Leonardo, et al.
Publicado: (2023) -
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience
por: Rossini, Roberta, et al.
Publicado: (2020) -
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry
por: Pepe, Martino, et al.
Publicado: (2023) -
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021) -
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
por: Selvarajah, A., et al.
Publicado: (2021)